Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.31363 | 52 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.23314 | 51 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.21333 | 50 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.18671 | 51 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.28534 | 54 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.37505 | 52 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.25676 | 49 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.3027 | 53 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.23381 | 52 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.81152 | 64 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.50037 | 58 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.50621 | 59 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.30304 | 53 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.29658 | 53 |